Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07355192
Recruiting
Hybrid Group Singing
Not applicable · United States · 1 site
Registry update: 13 Jul 2026
NCT07566156
Recruiting
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
Phase 3 · Canada, Germany, Spain, France, Italy, South Korea, Taiwan, United States · 66 sites
Registry update: 28 Oct 2026
NCT07628751
Recruiting
A Study of Standard Of Care Versus Radio Ablation in Early Stage HCC
Not applicable · Australia, Canada · 2 sites
Registry update: 5 Jun 2026
NCT07652047
Recruiting
A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 Tablets
Phase 1 · United States · 2 sites
Registry update: 17 Jun 2026
NCT07575399
Recruiting
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Phase 3 · Puerto Rico, United States · 57 sites
Registry update: 6 Nov 2026
NCT07441694
Recruiting
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Phase 1 · Australia, Belgium, Canada, Germany, Spain, France, United Kingdom, Italy, Japan, South Korea, United States · 54 sites
Registry update: 30 Oct 2026
NCT07567001
Recruiting
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Phase 3 · Argentina, Australia, Bulgaria, Brazil, Canada, China, Czechia, Germany, Denmark, Spain, France, United Kingdom, Greece, Israel, India, Italy, Japan, South Korea, Mexico, Malaysia, Netherlands, Poland, Puerto Rico, Taiwan, United States, South Africa · 830 sites
Registry update: 18 Aug 2026
NCT07613723
Recruiting
A Study to Test the Safety, Tolerability and Effect of ZI-MA4-1 for Patients With Locally Advanced or Metastatic Solid Malignancies
Phase 1 · United Kingdom · 2 sites
Registry update: 4 Sept 2026
NCT07513818
Recruiting
Implementing Low-dose ct Lung Cancer Screening in France.
Not applicable · France · 2 sites
Registry update: 5 Jun 2026
NCT07414277
Recruiting
CGM for Insulin-Treated T2DM During Post-Discharge Transition
Not applicable · China · 4 sites
Registry update: 24 Jun 2026
NCT07395336
Recruiting
Elacestrant and Exemestane for Patients With Pretreated HR+/HER2- Metastatic Breast Cancer and [18F] FES-avid Lesions (COMBINE)
Phase 2 · Italy · 1 site
Registry update: 14 May 2026
NCT07292012
Recruiting
Efficacy of MIrikizumab to Achieve Transmural Healing in patiENTs With Crohn's Disease
Phase 4 · France · 14 sites
Registry update: 4 Nov 2026
NCT07296744
Recruiting
Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)
Not applicable · United States · 26 sites
Registry update: 2 Nov 2026
NCT07492914
Recruiting
Neoadjuvant Sacituzumab Govitecan Plus Tagitanlimab for Resectable Head and Neck Squamous Cell Carcinoma
Phase 2 · China · 1 site
Registry update: 13 May 2026
NCT07540338
Recruiting
A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed Immediate-release Lithium Carbonate Capsule in Subjects With Bipolar I Disorder
Phase 1/2 · United States · 1 site
Registry update: 28 Jul 2026
NCT07595016
Recruiting
Clinical Validation of the Blood Pressure Measuring Device Withings BPM Pro 2 in Pregnancy and Pre-Eclampsia
Not applicable · Armenia · 1 site
Registry update: 3 Jun 2026
NCT07053319
Recruiting
SGLT2i, Pioglitazone, and Ketone Production in T2D
Phase 1 · United States · 1 site
Registry update: 17 Jul 2026
NCT07444047
Recruiting
MRI-Based Lesion Differentiation in Older Patients With Multiple Sclerosis
Not applicable · Norway · 1 site
Registry update: 1 Jun 2026
NCT07265674
Recruiting
A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
Phase 3 · United States · 18 sites
Registry update: 29 Sept 2026
NCT07516288
Recruiting
Safety and Efficacy of Second Infusion of FAP iCDC in End-stage Dilated Cardiomyopathy
Phase 1 · China · 1 site
Registry update: 2 Jul 2026

Ordered by registry start date. Freshness and sponsorship never change the order.